These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27404202)

  • 1. Vaccine Pricing and US Immunization Policies--Reply.
    Meissner HC
    JAMA; 2016 Jul; 316(2):226-7. PubMed ID: 27404202
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccine Pricing and US Immunization Policies.
    Schwartz JL
    JAMA; 2016 Jul; 316(2):226. PubMed ID: 27404201
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunization Policy and the Importance of Sustainable Vaccine Pricing.
    Meissner HC
    JAMA; 2016 Mar; 315(10):981-2. PubMed ID: 26857277
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on expanding the evidence base to inform vaccine introduction: Program costing and cost-effectiveness analyses.
    Andrus JK; Walker DG
    Vaccine; 2015 May; 33 Suppl 1():A2-3. PubMed ID: 25919161
    [No Abstract]   [Full Text] [Related]  

  • 7. Economic aspects of vaccines and immunizations.
    Hinman AR
    C R Acad Sci III; 1999 Nov; 322(11):989-94. PubMed ID: 10646095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the cost of delivering routine immunization in Honduras.
    Janusz CB; Castañeda-Orjuela C; Molina Aguilera IB; Felix Garcia AG; Mendoza L; Díaz IY; Resch SC
    Vaccine; 2015 May; 33 Suppl 1():A53-9. PubMed ID: 25919175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health economic research on vaccinations and immunisation practices--an introductory primer.
    Szucs TD
    Vaccine; 2005 Mar; 23(17-18):2095-103. PubMed ID: 15755578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost of tetanus toxoid injection using a jet-injector (Imule) in collective immunization in Senegal: comparison with injection using a syringe and resterilizable needle].
    Schlumberger M; Châtelet IP; Lafarge H; Genêt A; Gaye AB; Monnereau A; Sanou C; Diawara L; Gueye Y; Lang J
    Sante; 1999; 9(5):319-26. PubMed ID: 10657777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives on the development and use of economic evidence for immunization decision-making in a developing country.
    Molina-Aguilera IB
    Vaccine; 2015 May; 33 Suppl 1():A6-7. PubMed ID: 25919176
    [No Abstract]   [Full Text] [Related]  

  • 13. Foreword.
    Etienne CF
    Vaccine; 2015 May; 33 Suppl 1():A1. PubMed ID: 25919148
    [No Abstract]   [Full Text] [Related]  

  • 14. Analytics for vaccine economics and pricing: insights and observations.
    Robbins MJ; Jacobson SH
    Expert Rev Vaccines; 2015 Apr; 14(4):605-16. PubMed ID: 25435003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and Tanzania.
    Mvundura M; Lorenson K; Chweya A; Kigadye R; Bartholomew K; Makame M; Lennon TP; Mwangi S; Kirika L; Kamau P; Otieno A; Murunga P; Omurwa T; Dafrossa L; Kristensen D
    Vaccine; 2015 May; 33(23):2697-703. PubMed ID: 25865467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How important are airfreight rates and vaccine packaging in cost-saving efforts for the Expanded Programme on Immunization?
    Schreuder B; Arentsen H; Matosse M
    Bull World Health Organ; 1997; 75(4):315-21. PubMed ID: 9342890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ProVac initiative and evolving decision support.
    Sanderson CF
    Vaccine; 2015 May; 33 Suppl 1():A8-10. PubMed ID: 25919181
    [No Abstract]   [Full Text] [Related]  

  • 18. Determinants of routine immunization costing in Benin and Ghana in 2011.
    Ahanhanzo CD; Huang XX; Le Gargasson JB; Sossou J; Nyonator F; Colombini A; Gessner BD
    Vaccine; 2015 May; 33 Suppl 1():A66-71. PubMed ID: 25919178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing national immunization program supply chain management in Thailand: an economic analysis.
    Riewpaiboon A; Sooksriwong C; Chaiyakunapruk N; Tharmaphornpilas P; Techathawat S; Rookkapan K; Rasdjarmrearnsook A; Suraratdecha C
    Public Health; 2015 Jul; 129(7):899-906. PubMed ID: 26027451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gavi's balancing act: Accelerating access to vaccines while ensuring robust national decision-making for sustainable programmes.
    Sosler S; Kallenberg J; Johnson HL
    Vaccine; 2015 May; 33 Suppl 1():A4-5. PubMed ID: 25919172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.